Search

...

Researchers project that Canada could eliminate hepatitis C as a public health threat by 2030. Mathematical models show that this can be achieved with high ...

This program in Toronto, Ontario, used peer outreach workers to test people who inject drugs for hepatitis C and link them to care.

Antiviral agents for COVID-19

As the COVID-19 pandemic began sweeping around the world, many clinical trials were initiated to test drugs that were already approved for one condition ...

Remdesivir (GS-5734) was originally developed for the potential treatment of Ebola virus infection. However, in clinical trials it was not as effective as other ...

Researchers in North America, Europe and Asia conducted a randomized, placebo-controlled study of remdesivir in adults hospitalized with COVID-19. Analysis ...

In the midst of a major health emergency - widespread COVID-19 - researchers were able to conduct a well-designed study of remdesivir vs. placebo. Here are some ...

In the UK, scientists have established the Recovery trial to test several treatments for SARS-CoV-2 infection. A preliminary analysis has found that some people ...

One of the medicines that has been undergoing extensive testing in people with COVID-19 is a fixed-dose formulation of two drugs: lopinavir + ritonavir. In ...

Individual drugs that are approved to treat a well-known virus and which are then repurposed to treat a new and sometimes unrelated virus will likely have only ...

Scientists at the Emory Institute of Drug Development (EIDD) at Emory University in Atlanta have developed an antiviral drug they called EIDD-2801. This drug is ...